Skip to main content
Afaf E. Osman
( out of 34 reviews )

Afaf E. Osman, MD

Languages spoken: Arabic, English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Research North

Clinic 2D/E, BMT/Hematology
2000 Circle of Hope
Salt Lake City , UT 84112

Dr. Afaf E. Osman is an Assistant Professor specializing in Hematology and Hematologic Malignancies within the Division of Hematology at the University of Utah. Board certified in Hematology and Medical Oncology, Dr. Osman focuses on the diagnosis, management, and underlying mechanisms of clonal hematopoiesis, myeloid malignancies, and bone marrow failure syndromes.

After completing her Internal Medicine residency at Johns Hopkins University and Hematology and Oncology fellowship at the University of Chicago, Dr. Osman joined the faculty at the University of Utah in 2020. She is actively involved in multi-institutional studies and clinical trials aimed at improving the understanding and treatment of conditions such as acute myeloid leukemia (AML) and clonal cytopenias of undetermined significance (CCUS).

Dr. Osman's research centers on uncovering the genetic and inflammatory drivers of myeloid malignancies, with a focus on how these factors contribute to disease progression and therapeutic resistance. Her work emphasizes the translation of laboratory findings into clinical strategies to enhance patient outcomes. Dr. Osman is a member of American Society of Hematology, Society of Hematologic Oncology, and American Society of Clinical Oncology.

To schedule an appointment: New Patients: 801-585-4630 Returning Patients: 801-585-2626 or schedule through MyChart.

For questions regarding our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist (801) 587-4630.

Board Certification

American Board of Internal Medicine (Sub: Medical Oncology)
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Hematology)

Patient Rating

Patients consistently describe Dr. Osman as knowledgeable, thorough, and caring, noting she explains lab results and treatment options clearly and involves them in decision-making. Many comments highlight that she listens, anticipates questions, spends time with patients, follows conditions closely, and works with a supportive team. A small number of reviews mention occasional concerns about attentiveness or preparation, but overall feedback is strongly positive.

Generated via Patient Reviews

4.9 /5
( out of 34 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


2026-04-26
HUNTSMAN CANCER CENTER

Very knowledgeable and skilled physician. She made sure that I understood my diagnosis and the plan of care.

2026-03-17
HUNTSMAN CANCER CENTER

A wonderful kind and caring professional. I feel so safe in Doctor Osman hands.

2026-01-19
HUNTSMAN CANCER CENTER

Dr. Osman is wonderful to work with. Can take a complex diagnosis and explain it in a very understandable way, and it's evident that she cares about her patients in a way that is both professional and personal at the same time.

2025-09-08
HUNTSMAN CANCER CENTER

Dr Osman is amazing. Professional, smart, kind and caring. She asks questions and gives me positive answers

2025-06-10
HUNTSMAN CANCER CENTER

I like doctor Osman but hate sitting around for 3 hours

2025-02-17
HUNTSMAN CANCER CENTER

Very nice. Extremely helpful.

2025-02-13
HUNTSMAN CANCER CENTER

Dr Osman is amazing, caring and empathetic. I hate my cancer, but Dr Osman always has suggestions and options for me

2025-02-09
HUNTSMAN CANCER CENTER

SheÕs best!

2025-02-03
HUNTSMAN CANCER CENTER

It was wonderful to finally find someone with the experience and caring in the same office. Dr. Osman and entire staff are wonderful.

2025-02-02
HUNTSMAN CANCER CENTER

My experience with Dr Osman was good. The wait time to see her was not.

2024-11-05
HUNTSMAN CANCER CENTER

She is professional, smart and kind.

2024-11-03
HUNTSMAN CANCER CENTER

Dr Osman has been a tremendous advocate for my health care and that of my brother. She pays attention to detail and explains he processes in a way that is understandable.

2024-11-03
HUNTSMAN CANCER CENTER

She is a very knowledgable, kind and a caring person.

2024-11-01
HUNTSMAN CANCER CENTER

Dr. Osman is knowledgeable and is constantly searching for effective treatments. She is a great fit for me as she guides me through my disease process and treatment with a caring attitude. Wonderful provider!!

2024-10-29
HUNTSMAN CANCER CENTER

Exelent and very professional

2024-09-12
HUNTSMAN CANCER CENTER

I'm very pleased to have Dr. Osman as my Dr.

2024-07-07
HUNTSMAN CANCER CENTER

Dr. Osman seems to be very thorough and I can tell that she cares about my health.

2024-06-17
HUNTSMAN CANCER CENTER

Dr Osman understands and listens to my issues.Excellent and concerned Dr

2024-06-16
HUNTSMAN CANCER CENTER

Very caring doctor that listens to her patients. Makes decisions based on facts.

2024-05-27
HUNTSMAN CANCER CENTER

Dr. Osman is thorough and works very hard at figuring out how to treat my disease/disorder. I like how she sits down and discusses labs/test results; and draws out treatment options on paper. She is personable and caring. Plus she has a wonderful team supporting her.

2024-05-17
HUNTSMAN CANCER CENTER

Dr. Osman is very thoughtful and caring. She sits down with me to explain labs, tests, treatment plan and options. I'm grateful she is guiding me through this journey!

2024-04-29
HUNTSMAN CANCER CENTER

Very Professional yet Very Personable - Everything you want in a Doctor

2024-03-24
HUNTSMAN CANCER CENTER

Dr. Osman explains everything clearly and takes the time to explain if you don't understand.

2024-03-11
HUNTSMAN CANCER CENTER

Dr. Osman is knowledgeable about my condition and is concerned about my overall health. We always discuss my symptoms and treatment options to come up with the best plan. She is a wonderful provider!

2024-02-05
HUNTSMAN CANCER CENTER

She is kind and professional.

2024-01-30
HUNTSMAN CANCER CENTER

She is smart, patient and kind.

2024-01-29
HUNTSMAN CANCER CENTER

Dr. Osman is very caring. She manages my disease, symptoms, medications, and response to treatment while keeping me in the loop and involving me in my care. I feel she has my best interest and provides wonderful care!

2023-12-17
HUNTSMAN CANCER CENTER

Dr. Osman really listens and answers all my questions

2023-11-30
HUNTSMAN CANCER CENTER

She is professional, a very good listener and smart.

2023-11-15
HUNTSMAN CANCER CENTER

Dr. Osman is the perfect provider for me. She sits down and explains my test results, medications, options, and develops a plan with me for my best health. I like that Dr. Osman and her staff are caring and helpful!

2023-10-30
HUNTSMAN CANCER CENTER

She is our hero. She cares and is professional.

2023-10-15
HUNTSMAN CANCER CENTER

Dr. Osman is thoughtful and caring. She understands my health concerns and works with me for the best treatment for my blood disease. Absolutely a wonderful provider!

2023-10-08
HUNTSMAN CANCER CENTER

Attentive to my needs & questions

2023-10-01
HUNTSMAN CANCER CENTER

I love Dr. Osman she explains everything clearly and truly cares

2023-08-21
HUNTSMAN CANCER CENTER

She is amazing and kind, professional and so very, very smart.

2023-05-14
HUNTSMAN CANCER CENTER

She is a very compassionate person and very knowledgeable in her profession. We are happy with her as our Hematologist and in caring for Ken's disease Vexas.

2023-04-09
HUNTSMAN CANCER CENTER

I feel like I'm in good hands with Dr. Osman I trust that she is working toward my best interests.

2023-04-05
HUNTSMAN CANCER CENTER

Dr. Osman is caring and concerned about my health. I feel comfortable discussing my disease and treatment options; plus she consults with other physicians to assure I am getting the best care for me. Nothing but gratitude for her care!!

2023-04-03
HUNTSMAN CANCER CENTER

She was great. Only doctor Ive seen who looked at the whole picture.

2023-03-13
HUNTSMAN CANCER CENTER

Dr. Osman follows my disease closely and works for the best outcome. Wonderful care! Also, has a caring team!

2023-02-24
HUNTSMAN CANCER CENTER

Very difficult to get contact. All contact other than office visit is very difficult

2023-02-09
HUNTSMAN CANCER CENTER

I believe Dr. Osman has my best interest in treating me and my blood disease. She listens and offers treatment options while involving me in decisions. I like that she asks if I have questions, answers them, and then explains additional information that I did not think to ask. She also follows my condition closely. Great care and a great team working with her!!

2023-01-30
HUNTSMAN CANCER CENTER

Dr Osman is very good at explaining my condition and possible treatment. She took time with me and answered my questions. She is also very kind. I have complete confidence in her I feel fortunate that she is my doctor

2022-12-29
HUNTSMAN CANCER CENTER

Dr. Osman is caring and concerned about my health. She reviews where we are with labs/medications, anticipates questions, and involves me in decisions about the treatment plan. Wonderful provider!!

2022-12-25
HUNTSMAN CANCER CENTER

Dr Osman is a very caring physician. She listens to your needs and finds the best options for you.

2022-12-17
HUNTSMAN CANCER CENTER

She is a fantastic doctor and we experienced a Virtual Visit with her because she was sick.

2022-12-12
HUNTSMAN CANCER CENTER

Dr. Osman is perfect for me. She is thorough, caring, and looks out for my best health.

2022-12-10
HUNTSMAN CANCER CENTER

Dr. Osman is sensitive, caring and thorough in her assessment of my overall health condition. She doesn't just look at the results of my blood test, but takes into account the composite of the many variables that make up my overall health.

2022-11-19
Huntsman Cancer Institute

Dr. Osman is awesome! She was concerned about changes in my health, thorough with figuring it out, and discussed the meaning/treatment options. Also stays on top of follow-ups. I am grateful for her care!

2022-10-20
HUNTSMAN CANCER CENTER

Dr. Osman was caring and concerned about my situation. She explained my labs and treatment options while involving me in decisions. She is a wonderful provider and has a great team working with her. I know I am In good hands!!

2022-09-24
HUNTSMAN CANCER CENTER

I feel that I am in good hands with Dr. Osman and her health care team! She is caring, explains labs and treatment options, and includes me in all discussions about treatment. Excellent!

2022-08-30
HUNTSMAN CANCER CENTER

Good

2022-08-09
HUNTSMAN CANCER CENTER

Provider was on her phone several times during the visit and seemed preoccupied with being elsewhere. Did not seemed fully prepared for providing explanation of lab results.

2022-07-07
HUNTSMAN CANCER CENTER

Very good

2022-04-15
HUNTSMAN CANCER CENTER

Good

2022-03-27
HUNTSMAN CANCER CENTER

Dr. Osman is wonderful! She is thorough, explains labs and treatment, and includes me in my care. I know I am getting great care! The nursing staff are also wonderful to work with.

2022-03-13
HUNTSMAN CANCER CENTER

Dr Osman is so knowledgeable and willing to explain and answer all questions. So relieved to be under her care.

2022-02-28
HUNTSMAN CANCER CENTER

Dr Osman is professional, kind and really listens to my concerns

2022-02-19
HUNTSMAN CANCER CENTER

Dr Osman was very knowledgeable and I felt assured that I was at the right place to get help. I am so grateful to have her as my doctor.

2022-01-30
HUNTSMAN CANCER CENTER

Dr. Osman is professional, kind and amazing

2022-01-25
HUNTSMAN CANCER CENTER

We met two new doctors. Both were very good.

2021-12-29
HUNTSMAN CANCER CENTER

I am grateful for Dr. Osman's care. She listens to my concerns and I feel has my best Interest in mind. Her explanations are thorough, answers my questions, and includes me in my care. Wonderful provider!! `

2021-12-08
HUNTSMAN CANCER CENTER

Dr Osmond is professional, knowledgeable and caring. I feel very safe in her care.

2021-11-08
HUNTSMAN CANCER CENTER

Excellent experience with Dr. Osman. I would strongly recommend her to others.

2021-10-31
HUNTSMAN CANCER CENTER

I felt very safe and secure

2021-09-19
HUNTSMAN CANCER CENTER

Good visit. Dr. Concentrated on health issues. Repeated questions to insurer my understanding. Gave options for future actions. Spent plenty of time for questions.

2021-08-03
HUNTSMAN CANCER CENTER

Dr. Osman is excellent in all areas. I find her easy to talk with and includes me in my care. Top notch!!

2021-07-27
HUNTSMAN CANCER CENTER

Fairly good

2021-06-04
HUNTSMAN CANCER CENTER

Dr. Osman is wonderful. She includes me in my care, anticipates questions and answers mine, and provides education.

2021-05-21
HUNTSMAN CANCER CENTER

Dr. Osman explained everything: my concerns and questions. She anticipates what questions I may have!

2021-05-02
HUNTSMAN CANCER CENTER

I really liked Dr Osman.

2021-03-22
HUNTSMAN CANCER CENTER

Very Good at listening to Questions and giving plane language answers.

2020-12-21
HUNTSMAN CANCER CENTER

Dr. Osman was excellent with the discussion of the problem and answering questions. She involved me in the discussion and decisions.

2020-12-16
HUNTSMAN CANCER CENTER

Great visit! Dr Osman is the first in a long line of providers to diagnose my problem. She ordered the right tests, arranged for expert analysis and came up with an educated diagnosis.

2020-11-30
HUNTSMAN CANCER CENTER

I am glad that my doctor was there to make sure that everything was OK preventative is better than not

2020-11-29
HUNTSMAN CANCER CENTER

I was impressed and cared for.

2020-11-01
HUNTSMAN CANCER CENTER

all were very informative


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Dr. Afaf E. Osman is an Assistant Professor specializing in Hematology and Hematologic Malignancies within the Division of Hematology at the University of Utah. Board certified in Hematology and Medical Oncology, Dr. Osman focuses on the diagnosis, management, and underlying mechanisms of clonal hematopoiesis, myeloid malignancies, and bone marrow failure syndromes.

After completing her Internal Medicine residency at Johns Hopkins University and Hematology and Oncology fellowship at the University of Chicago, Dr. Osman joined the faculty at the University of Utah in 2020. She is actively involved in multi-institutional studies and clinical trials aimed at improving the understanding and treatment of conditions such as acute myeloid leukemia (AML) and clonal cytopenias of undetermined significance (CCUS).

Dr. Osman's research centers on uncovering the genetic and inflammatory drivers of myeloid malignancies, with a focus on how these factors contribute to disease progression and therapeutic resistance. Her work emphasizes the translation of laboratory findings into clinical strategies to enhance patient outcomes. Dr. Osman is a member of American Society of Hematology, Society of Hematologic Oncology, and American Society of Clinical Oncology.

To schedule an appointment: New Patients: 801-585-4630 Returning Patients: 801-585-2626 or schedule through MyChart.

For questions regarding our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist (801) 587-4630.

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor (Clinical)
Academic Divisions Hematology & Hematologic Malignancies
Board Certification
American Board of Internal Medicine (Sub: Medical Oncology)
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Hematology)

Education history

Certification Premedical Program - Weill Cornell Medical College in Qatar Pre Med
Doctoral Training Medicine - Weill Cornell Medical College in Qatar M.D.
Residency Internal Medicine - Johns Hopkins Hospital Resident
Fellowship Hematology & Oncology - University of Chicago Clinical Fellow
Fellowship Leukemia - University of Chicago Research Fellow

Selected Publications

Journal Article

  1. Stubbins RJ, Arnovitz S, Vagher J, Asom A, Perpich M, Pies M, Akpan IJ, Chew E, Bridgers J, Karsan A, Rodgers C, Koppayi A, Basdag H, Drazer MW, Das S, Cheng J, Osman AEG, Godley L (2025). Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants. Leukemia,
  2. Vagher J, Zakas A, Donovan L, Shoger K, Naumer A, Bly J, Smith-Simmer K, Maese L, Schiffman J, Kohlmann W, Garzon R, Churpek JE, Osman AE (2025). Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni Syndrome. JCO precision oncology, 9, e2400860.
  3. Greenberg PL, Stone RM, Abaza Y, Al-Kali A, Anand S, Ball B, Bennett JM, Borate U, Brunner AM, Chai-Ho W, Curtin P, DeZern AE, Gaensler K, Gahvari Z, Garcia-Manero G, Griffiths EA, Haque T, Jacoby M, Jonas BA, Keel S, Khanal R, Kishtagari A, Madanat Y, Maness LJ, McCurdy SR, McMahon C, Odenike O, Osman A, Reddy VV, Sallman DA, Sayar H, Shallis R, Singh A, Tanaka T, Thota S, Kovach E, Nguyen J, Hochstetler (2025). NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025. Journal of the National Comprehensive Cancer Network, 23(3), 66-75.
  4. Li P, Alnoor FNU, Xie W, Williams M, Feusier J, Ding Y, Zhao X, Zheng G, Zhao C, Zieske AW, Zu Y, Raess PW, Tantravahi S, Osman A, Patel AB, Tashi T, Patel JL, Matynia AP, Menon MP, Miles RR, Jacobsen JR, George TI, Sborov DW, Szankasi P, Rindler P, Close D, Ohgami R (2025). Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDS. Leukemia, 39(1), 248-256.
  5. Jin N, Hoyd R, Yilmaz AS, Zhu J, Liu Y, Jagjit Singh MS, Grencewicz DJ, Mo X, Kalady MF, Rosenberg DW, Dravillas CE, Singer EA, Carpten JD, Chan CHF, Churchman ML, Denko N, Di Clemente F, Dodd RD, Eljilany I, Fei N, Hardikar S, Ikeguchi AP, Ma A, Ma Q, McCarter MD, Osman AEG, Riedlinger G, Robinson LA, Schneider BP, Tarhini AA, Tinoco G, Figueiredo JC, Zakharia Y, Ulrich CM, Tan AC, Spakowicz (2025). Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer. Cancer research communications, 5(11), 1985-1997.
  6. Liu X, Tang YH, Blachly J, Edge S, Jakubek YA, McCarter M, Naqash AR, Nepple KG, Osman A, Reilley MJ, Riedlinger G, Salhia B, Schneider BP, Shriver C, Churchman ML, Rounbehler RJ, Teer JK, Gillis N, Teng (2025). qcCHIP: an R package to identify clonal hematopoiesis variants using cohort-specific data characteristics. Bioinformatics (Oxford, England), 41(9),
  7. Osman AEG, Rets A, Patel A (2024). KRAS mutations, autoimmunity and female sex in chronic myelomonocytic leukemia. Leukemia research, 138, 107466.
  8. Wang C, Ma A, Li Y, McNutt ME, Zhang S, Zhu J, Hoyd R, Wheeler CE, Robinson LA, Chan CHF, Zakharia Y, Dodd RD, Ulrich CM, Hardikar S, Churchman ML, Tarhini AA, Singer EA, Ikeguchi AP, McCarter MD, Denko N, Tinoco G, Husain M, Jin N, Osman AEG, Eljilany I, Tan AC, Coleman SS, Denko L, Riedlinger G, Schneider BP, Spakowicz D, Ma Q, exORIEN Consortiu (2024). A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset. Cancer research communications, 4(2), 293-302.
  9. Wang C, Ma A, Li Y, McNutt ME, Zhang S, Zhu J, Hoyd R, Wheeler CE, Robinson LA, Chan CHF, Zakharia Y, Dodd RD, Ulrich CM, Hardikar S, Churchman ML, Tarhini AA, Singer EA, Ikeguchi AP, McCarter MD, Denko N, Tinoco G, Husain M, Jin N, Osman AEG, Eljilany I, Tan AC, Coleman SS, Denko L, Riedlinger G, Schneider BP, Spakowicz D, Ma Q, exORIEN Consortiu (2024). A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset. Cancer research communications, 4(2), 293-302.
  10. Dravillas CE, Coleman SS 4th, Hoyd R, Caryotakis G, Denko L, Chan CHF, Churchman ML, Denko N, Dodd RD, Eljilany I, Hardikar S, Husain M, Ikeguchi AP, Jin N, Ma Q, McCarter MD, Osman AEG, Robinson LA, Singer EA, Tinoco G, Ulrich CM, Zakharia Y, Spakowicz D, Tarhini AA, Tan AC, exORIEN Consortiu (2024). The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors. Cancer research communications, 4(8), 1978-1990.
  11. Benej M, Hoyd R, Kreamer M, Wheeler CE, Grencewicz DJ, Choueiry F, Chan CHF, Zakharia Y, Ma Q, Dodd RD, Ulrich CM, Hardikar S, Churchman ML, Tarhini AA, Robinson LA, Singer EA, Ikeguchi AP, McCarter MD, Tinoco G, Husain M, Jin N, Tan AC, Osman AEG, Eljilany I, Riedlinger G, Schneider BP, Benejova K, Kery M, Papandreou I, Zhu J, Denko N, Spakowicz D, exORIEN Consortiu (2024). The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal Cancer. Cancer research communications, 4(7), 1690-1701.
  12. Xie Z, Komrokji RS, Al-Ali N, Regelson A, Geyer S, Patel AA, Saygin C, Zeidan AM, Bewersdorf JP, Mendez LM, Kishtagari A, Zeidner JF, Coombs CC, Madanat YF, Chung SS, Badar T, Foran JM, Desai P, Tsai C, Griffiths EA, Al Malki MM, Amanam I, Lai C, Deeg HJ, Ades L, Arana-Yi C, Osman AE, Dinner SN, Abaza Y, Taylor J, Chandhok NS, Soong D, Brunner AM, Carraway HE, Singh A, Elena C, Ferrari J, Galli A, Pozzi S, Padron E, Patnaik MM, Malcovati L, Savona MR, Al-Kali (2024). Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence. Blood,
  13. Rosenberg J (2024). Glycemic Marker Correlation with Collagen Denaturation and Non-Enzymatic Collagen Cross-Linking in Age-Associated Bone Resistance. JOM (Warrendale, Pa., 76(10), 5684-5691.
  14. Wheeler CE, Coleman SS 4th, Hoyd R, Denko L, Chan CHF, Churchman ML, Denko N, Dodd RD, Eljilany I, Hardikar S, Husain M, Ikeguchi AP, Jin N, Ma Q, McCarter MD, Osman AEG, Robinson LA, Singer EA, Tinoco G, Ulrich CM, Zakharia Y, Spakowicz D, Tarhini AA, Tan A (2023). The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors.
  15. Wang C, Ma A, McNutt ME, Hoyd R, Wheeler CE, Robinson LA, Chan CHF, Zakharia Y, Dodd RD, Ulrich CM, Hardikar S, Churchman ML, Tarhini AA, Singer EA, Ikeguchi AP, McCarter MD, Denko N, Tinoco G, Husain M, Jin N, Osman AEG, Eljilany I, Tan AC, Coleman SS 4th, Denko L, Riedlinger G, Schneider BP, Spakowicz D, Ma (2023). A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset.
  16. Osman AEG, Mencia-Trinchant N, Saygin C, Moma L, Kim A, Housman G, Pozsgai M, Sinha E, Chandra P, Hassane DC, Sboner A, Sangani K, DiNardi N, Johnson C, Wallace SS, Jabri B, Luu H, Guzman ML, Desai P, Godley L (2023). Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones. Blood advances, 7(9), 1910-1914.
  17. Yu B, Osman AEG, Sladojevic N, Prabhu N, Tai HC, Chen D, Perla G, Park L, Larson RA, Liao J (2022). Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity. JACC. CardioOncology, 4(3), 371-383.
  18. Osman A, Mencia-Trinchant N, Saygin C, Moma L, Kim A, Housman G, Pozsgai MJ, Sinha E, Chandra P, Hassane DC, Sboner A, Sangani K, DiNardi N, Johnson C, Wallace SS, Jabri B, Luu H, Guzman ML, Desai P, Godley L (2022). Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones. Blood advances, 7(9), 1910-1914.
  19. Croci DM, Gamboa NT, Osman AEG, Maese L, Mazur M, Bisson EF, Dailey A (2022). Solitary manifestations of primary B-lymphoblastic lymphoma of the spine: Systematic literature review with case illustration. Clinical neurology and neurosurgery, 212, 107064.
  20. Yu B (2022). Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity. JACC. CardioOncology, 4(3), 371-383.
  21. Feusier JE, Madsen MJ, Avery BJ, Williams JA, Stephens DM, Hu B, Osman AEG, Glenn MJ, Camp N (2021). Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk. Journal of translational genetics and genomics, 5, 189-199.
  22. Feusier J.E (2021). Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk. Journal of translational genetics and genomics, 5(2), 189-199.
  23. Feurstein S, Adegunsoye A, Mojsilovic D, Vij R, DePersia AHW, Rajagopal PS, Osman A, Collins RH, Kim RH, Gore SD, Greenberg P, Godley LA, Li Z, Del Gaudio D, Subramanian HP, Das S, Walsh T, Gulsuner S, Segal JP, Husain AN, Gurbuxani S, King MC, Strek ME and Churpek J (2020). Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations. Blood advances, 4(19), 4873-4886.
  24. Osman A, Gocke CD, Gladstone D (2017). Change in IgHV Mutational Status of CLL Suggests Origin From Multiple Clones. Clinical lymphoma, myeloma & leukemia, 17(2), 97-99.
  25. Osman A, et a (2014). Sudden Worsening of DRESS Syndrome on Tapering Steroid Dose with Dramatic Improvement on N-acetylcysteine and Steroid Dose Escalation. 6(2), 101-10.

Review

  1. Liu J, Osman AEG, Bolton K, Godley L (2023). Germline predisposition to clonal hematopoiesis. Leukemia research, 132, 107344.
  2. Liu J, Osman AEG, Bolton K, Godley L (2023). Germline predisposition to clonal hematopoiesis. Leukemia research, 132, 107344.
  3. Croci DM, Gamboa NT, Osman AEG, Maese L, Mazur M, Bisson EF, Dailey A (2022). Solitary manifestations of primary B-lymphoblastic lymphoma of the spine: Systematic literature review with case illustration. Clinical neurology and neurosurgery, 212, 107064.
  4. Osman AEG, Deininger MW (2021). Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions. [Review]. Blood Rev, 49, 100825.
  5. Osman A, Patel JL (2021). Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis. [Review]. Clin Chem, 67, (8), 1062-1070.
  6. Osman AEW (2021). When are idiopathic and clonal cytopenias of unknown significance (ICUS or CCUS)?. Hematology. American Society of Hematology. Education Program, 2021(1), 399-404.
  7. Osman AEG, Luke JJ (2019). The Impact of the Fecal Microbiome on Cancer Immunotherapy. [Review]. BioDrugs, 33, (1), 1-7.
  8. Akpan IJ, Osman AEG, Drazer MW, Godley L (2018). Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies. Current hematologic malignancy reports, 13(6), 426-434.
  9. Osman AEG, Anderson J, Churpek JE, Christ TN, Curran E, Godley LA, Liu H, Thirman MJ, Odenike T, Stock W, Larson R (2018). Treatment of Acute Promyelocytic Leukemia in Adults. Journal of oncology practice, 14(11), 649-657.

Case Report

  1. Osman A, Galiatsatos P, Bose S, Danoff (2017). Rheumatoid arthritis causing diffuse alveolar haemorrhage: a novel therapeutic approach. BMJ case reports, 2017,

Abstract

  1. Osman A, Yu B, Glavin N, Polonsky T, Liao J, Larson R (2018). ABL Tyrosine Kinase Inhibitors (TKIs) are Associated with Increased Rho-Associated Kinase (ROCK) Activity that May Contribute to Vascular Toxicity in Patients with Chronic Myeloid Leukemia (CML). Poster session: 632 Chronic Myeloid Leukemia: Therapy, American Society of Hematology 60th Annual Meeting, San Diego, CA. 132(Suppl 1), 1739.
  2. Osman A, Galiatsatos P, Bose (2017). Diffuse Alveolar Hemorrhage as a Rare Manifestation of Rheumatoid Arthritis. Poster session presented at the Autoimmune Lung Disease: Case Reports Thematic Poster Session. American Thoracic Society International Conference, Washington, DC. 195, A1460.

Other

  1. Osman AEG, Luke J (2019). The Gut Microbiome and Cancer Immunotherapy. 4(8), 14, 15.